# A double-blind, placebo-controlled, randomized phase III trial of chemotherapy plus epigenetic therapy with hydralazine valproate for advanced cervical cancer. Preliminary results

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-double-blind-placebo-controlled-randomized-phase-iii-trial-of-chemotherapy/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jaime Coronel,Lucely Cetina,Irlanda Pacheco,Catalina Trejo‐Becerril,Aurora González‐Fierro,Erick de la Cruz‐Hernandez,Enrique Pérez‐Cárdenas,Lucía Taja‐Chayeb,Daymi Arias-Bofill,Myrna Candelaria,Sílvia Vidal,Alfonso Dueñas‐González |
| Citations | 133 |
| DOI | 10.1007/s12032-010-9700-3 |
| Fields | Biochemistry, Genetics and Molecular Biology,Social Sciences |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2087493660 |
| PMID | 20931299 |
| Type | article |
| Year | 2010 |

## Paper authors

- [Lucely Cetina](https://scholariq.org/researchers/lucely-cetina/)

## Paper primary topic

- [Histone Deacetylase Inhibitors Research](https://scholariq.org/topics/histone-deacetylase-inhibitors-research/)

## Paper topics

- [Histone Deacetylase Inhibitors Research](https://scholariq.org/topics/histone-deacetylase-inhibitors-research/)
- [Epigenetics and DNA Methylation](https://scholariq.org/topics/epigenetics-and-dna-methylation/)
- [Family Support in Illness](https://scholariq.org/topics/family-support-in-illness/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.